RXO (RXO) Misses Q1 EPS by 7c ; Provides Outlook

RXO (NYSE: RXO) reported Q1 EPS of ($0.03), $0.07 worse than the analyst estimate of $0.04. Revenue for the quarter came in at $913 million versus the consensus estimate of $952.12 million.

Second-Quarter Outlook

RXO expects second-quarter 2024 companywide adjusted EBITDA to be between $24 million and $30 million. The company expects second-quarter 2024 brokerage gross margin to be between 13% and 15%.

For earnings history and earnings-related data on RXO (RXO) click here.

You May Also Be Interested In

• Ennis (EBF) Reports In-Line Q1 EPS
• Micron Technology (MU) PT Raised to $1,550 at Needham
• AbbVie agrees to acquire Apogee Therapeutics for $10.9 billion